共 50 条
- [1] Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock CRITICAL CARE, 2010, 14 (02):
- [2] Drotrecogin alfa (Activated) for the treatment of severe sepsis and septic shock AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (04): : 205 - 214
- [4] Drotrecogin Alfa (Activated) in Septic Shock NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10): : 968 - 969
- [5] Variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock: a meta-analysis INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (09): : 12976 - 12985
- [7] Clinical trials in severe sepsis with drotrecogin alfa (activated) CRITICAL CARE, 2007, 11 (Suppl 5):
- [8] Drotrecogin alfa (activated) in severe sepsis NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01): : 95 - 95
- [9] Drotrecogin alfa (activated) in severe sepsis LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 108 - 109
- [10] Drotrecogin Alfa (Activated) in Septic Shock Reply NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (10): : 969 - 969